825 related articles for article (PubMed ID: 33417599)
1. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
[TBL] [Abstract][Full Text] [Related]
2. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
Li X; Shen A; Zhao Y; Xia J
Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
[TBL] [Abstract][Full Text] [Related]
3. An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study.
Ren F; Yang C; Feng K; Shang Q; Liu J; Kang X; Wang X; Wang X
Aging (Albany NY); 2024 Apr; 16(8):7101-7118. PubMed ID: 38663930
[TBL] [Abstract][Full Text] [Related]
4. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study.
Chauquet S; Zhu Z; O'Donovan MC; Walters JTR; Wray NR; Shah S
JAMA Psychiatry; 2021 Jun; 78(6):623-631. PubMed ID: 33688928
[TBL] [Abstract][Full Text] [Related]
5. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
Zhou S; Tian Y; Song X; Xiong J; Cheng G
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
[TBL] [Abstract][Full Text] [Related]
6. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of gene expression quantitative trait loci in brain.
Kim Y; Xia K; Tao R; Giusti-Rodriguez P; Vladimirov V; van den Oord E; Sullivan PF
Transl Psychiatry; 2014 Oct; 4(10):e459. PubMed ID: 25290266
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data.
Kibinge NK; Relton CL; Gaunt TR; Richardson TG
Am J Hum Genet; 2020 Jun; 106(6):885-892. PubMed ID: 32413284
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia, Bipolar Disorder, and Alzheimer's Disease are not Causal Factors of Bone Mineral Density: A Mendelian Randomization Analysis.
Cui Z; Meng X; Zhuang S; Liu Z; Zhou F; Tian Y
Calcif Tissue Int; 2020 Feb; 106(2):131-146. PubMed ID: 31679055
[TBL] [Abstract][Full Text] [Related]
10. Association between SNPs and gene expression in multiple regions of the human brain.
Kim S; Cho H; Lee D; Webster MJ
Transl Psychiatry; 2012 May; 2(5):e113. PubMed ID: 22832957
[TBL] [Abstract][Full Text] [Related]
11. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
Su WM; Gu XJ; Dou M; Duan QQ; Jiang Z; Yin KF; Cai WC; Cao B; Wang Y; Chen YP
J Neurol Neurosurg Psychiatry; 2023 Nov; 94(11):954-961. PubMed ID: 37349091
[TBL] [Abstract][Full Text] [Related]
12. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders.
Liu J; Cheng Y; Li M; Zhang Z; Li T; Luo XJ
Neuropsychopharmacology; 2023 Jan; 48(2):270-280. PubMed ID: 36114287
[TBL] [Abstract][Full Text] [Related]
14. Set-Based Rare Variant Expression Quantitative Trait Loci in Blood and Brain from Alzheimer Disease Study Participants.
Patel D; Zhang X; Farrell JJ; Lunetta KL; Farrer LA
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804025
[TBL] [Abstract][Full Text] [Related]
15. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders.
O'Brien HE; Hannon E; Hill MJ; Toste CC; Robertson MJ; Morgan JE; McLaughlin G; Lewis CM; Schalkwyk LC; Hall LS; Pardiñas AF; Owen MJ; O'Donovan MC; Mill J; Bray NJ
Genome Biol; 2018 Nov; 19(1):194. PubMed ID: 30419947
[TBL] [Abstract][Full Text] [Related]
16. Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer's disease.
Gockley J; Montgomery KS; Poehlman WL; Wiley JC; Liu Y; Gerasimov E; Greenwood AK; Sieberts SK; Wingo AP; Wingo TS; Mangravite LM; Logsdon BA
Genome Med; 2021 May; 13(1):76. PubMed ID: 33947463
[TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.
Ouyang Y; Chen Y; Chen K; Tang Z; Shi G; Qu C; Zhang K; Yang H
Hum Genomics; 2024 Apr; 18(1):43. PubMed ID: 38659056
[TBL] [Abstract][Full Text] [Related]
19. Novel DNA methylation loci and genes showing pleiotropic association with Alzheimer's dementia: a network Mendelian randomization analysis.
Liu D; Wang Y; Jing H; Meng Q; Yang J
Epigenetics; 2022; 17(7):746-758. PubMed ID: 34461811
[TBL] [Abstract][Full Text] [Related]
20. MRLocus: Identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity.
Zhu A; Matoba N; Wilson EP; Tapia AL; Li Y; Ibrahim JG; Stein JL; Love MI
PLoS Genet; 2021 Apr; 17(4):e1009455. PubMed ID: 33872308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
